文献速递银屑病与炎症性皮肤病毛发、甲与色素性疾病

甲银屑病与甲扁平苔藓:诊断和治疗进展

Nail psoriasis and nail lichen planus: Updates on diagnosis and management.
PubMed 文献 · J Am Acad Dermatol · 2023-11-24

本文综述了甲银屑病和甲扁平苔藓的诊断技术、严重程度评分系统及共识治疗推荐,涉及皮肤镜、毛细血管镜和超声等诊断手段,以及根据受累甲数量(≤3个或>3个)分层的治疗策略和新兴生物制剂与JAK抑制剂等疗法。

要点

  • 甲银屑病和甲扁平苔藓诊断常延迟,尤其无皮肤表现时,需提高识别。
  • 诊断技术聚焦皮肤镜、毛细血管镜和超声。
  • 治疗按受累甲数量≤3个或>3个分层,新兴疗法包括JAK抑制剂等。

核心结论

  • 需提高对炎症性甲病的认识并扩展管理策略以改善患者结局。

研究设计与样本

  • 通过PubMed数据库对甲银屑病和甲扁平苔藓诊断技术或治疗方式的文献进行更新综述。

主要发现

  • 诊断技术研究集中于皮肤镜、毛细血管镜和超声。
  • 治疗按受累甲数量分为≤3个和>3个两类。
  • 甲银屑病近期研究的治疗药物包括brodalumab、tildrakizumab、risankizumab、deucravacitinib和bimekizumab。
  • 甲扁平苔藓的新兴治疗包括JAK抑制剂和病灶内富血小板血浆注射。

关键数值与推荐

  • 治疗分层依据受累甲数量:≤3个或>3个。

临床怎么用

  • 临床中应结合皮肤镜、毛细血管镜和超声辅助诊断炎症性甲病。
  • 根据受累甲数量选择治疗策略,并关注新兴疗法证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory diseases of the nail, including nail psoriasis and nail lichen planus, are associated with significant disease burden and have a negative impact on quality of life. Diagnosis is often delayed, especially when patients present without cutaneous findings. Therefore, recognizing clinical signs and symptoms of inflammatory nail diseases, and initiating timely and appropriate treatment, is of utmost importance. OBJECTIVE: We review recent studies on diagnostic techniques, discuss severity grading and scoring systems, and describe consensus treatment recommendations for nail psoriasis and nail lichen planus. METHODS: An updated literature review was performed using the PubMed database on studies assessing diagnostic techniques or treatment modalities for nail psoriasis and nail lichen planus. RESULTS: Recent studies on diagnostic techniques for inflammatory nail disease have focused on use of dermoscopy, capillaroscopy, and ultrasound modalities. Treatment of these conditions is dichotomized into involvement of few (≤3) or many (>3) nails. Recent psoriatic therapeutics studied for nail outcomes include brodalumab, tildrakizumab, risankizumab, deucravacitinib, and bimekizumab, while emerging treatments for nail lichen planus include JAK inhibitors and intralesional platelet rich plasma injections. CONCLUSIONS: We emphasize the need for increased awareness and expanded management strategies for inflammatory nail diseases to improve patient outcomes.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Hwang JK, Grover C, Iorizzo M, et al. Nail psoriasis and nail lichen planus: Updates on diagnosis and management. J Am Acad Dermatol. 2023. PMID: 38007038. doi:10.1016/j.jaad.2023.11.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。